ICAM1 and neoplasm: We further analyzed the correlation between plasma ICAM1 level in PHC patients and tumor progression and metastasis, and the results showed that plasma ICAM1 levels in PHC patients with tumor progression were higher (P < 0.01, Figure 2(a)).